Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    20851928 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Leukotriene Polymorphisms and Montelukast Response - Ancillary to LoDo Trial
Conditions: Asthma;   Lung Diseases
Intervention:
2 Completed The Leukotriene Modifier Or Corticosteroid or Corticosteroid-Salmeterol Trial (The LOCCS Trial)
Condition: Asthma
Interventions: Drug: fluticasone;   Drug: montelukast;   Drug: fluticasone/salmeterol combination
3 Completed Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma
Condition: Asthma
Intervention: Drug: levalbuterol

Indicates status has not been verified in more than two years